Photo of the Week: Cell Therapy at the Biopharmaceutical Development Program (BDP)

The Biopharmaceutical Development Program (BDP) offers resources for, and expertise in, the development of investigational biological products that move promising treatments for cancer, rare diseases, AIDS, and infectious diseases into clinical trials. Here, BDP staff produce CAR T cell treatments for pediatric cancer patients participating in early-phase clinical trials.

The BDP focuses on products that are in early development, beginning with the demonstration of product feasibility. Following process development and biomolecular characterization, we move these products through manufacturing for Phase I/II clinical trials. The Biopharmaceutical Development Program (BDP), established in 1993, is funded by NCI's Division of Cancer Treatment and Diagnosis (DCTD).

Photo credit: Senad Diglisic, Biopharmaceutical Development Program